Taysha Gene Therapies (TSHA)
(Delayed Data from NSDQ)
$3.09 USD
0.00 (0.00%)
Updated May 20, 2024 04:00 PM ET
After-Market: $3.09 0.00 (0.00%) 7:16 PM ET
3-Hold of 5 3
F Value C Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/12/24 |
---|---|
Current Quarter | -0.10 |
EPS Last Quarter | -0.10 |
Last EPS Surprise | 9.09% |
ABR | 1.09 |
Earnings ESP
|
8.06% |
---|---|
Current Year | -0.41 |
Next Year | -0.43 |
EPS (TTM) | -0.26 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.62M | 3.66M | 14.52M | 11.33M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 4.00M | 4.10M | 16.06M | 13.99M |
Low Estimate | 3.41M | 3.41M | 13.64M | 8.00M |
Year ago Sales | 2.40M | 4.75M | 15.45M | 14.52M |
Year over Year Growth Est. | 50.83% | -22.88% | -6.05% | -21.95% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.10 | -0.10 | -0.41 | -0.43 |
# of Estimates | 3 | 3 | 5 | 3 |
Most Recent Consensus | NA | NA | -0.53 | NA |
High Estimate | -0.08 | -0.08 | -0.30 | -0.34 |
Low Estimate | -0.12 | -0.11 | -0.53 | -0.50 |
Year ago EPS | -0.38 | -0.13 | -0.96 | -0.41 |
Year over Year Growth Est. | 73.68% | 23.08% | 57.29% | -5.37% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 1 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 0 | 0 | 2 | 0 |
Down Last 7 Days | 1 | 0 | 2 | 1 |
Down Last 30 Days | 1 | 0 | 2 | 1 |
Down Last 60 Days | 1 | 1 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.10 | -0.10 | -0.41 | -0.43 |
7 Days Ago | -0.11 | -0.11 | -0.39 | -0.46 |
30 Days Ago | -0.11 | -0.11 | -0.39 | -0.46 |
60 Days Ago | -0.10 | -0.10 | -0.45 | NA |
90 Days Ago | -0.10 | -0.10 | -0.45 | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.10 | -0.08 | -0.44 | -0.43 |
Zacks Consensus Estimate | -0.10 | -0.10 | -0.41 | -0.43 |
Earnings ESP | 8.06% | 17.24% | -7.03% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.10 | 0.35 | -0.13 | -0.38 | NA |
Estimate | -0.11 | -0.09 | -0.13 | -0.31 | NA |
Difference | 0.01 | 0.44 | 0.00 | -0.07 | 0.10 |
Surprise | 9.09% | 488.89% | 0.00% | -22.58% | 118.85% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more